A citation-based method for searching scientific literature

Jennifer L Pike, Michael R Irwin. Brain Behav Immun 2006
Times Cited: 68







List of co-cited articles
735 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The relationship of depression and stressors to immunological assays: a meta-analytic review.
E P Zorrilla, L Luborsky, J R McKay, R Rosenthal, A Houldin, A Tax, R McCorkle, D A Seligman, K Schmidt. Brain Behav Immun 2001
602
41

Inflammatory markers and sleep disturbance in major depression.
Sarosh J Motivala, Avishay Sarfatti, Luis Olmos, Michael R Irwin. Psychosom Med 2005
198
25

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
25

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
25

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
U H Frommberger, J Bauer, P Haselbauer, A Fräulin, D Riemann, M Berger. Eur Arch Psychiatry Clin Neurosci 1997
279
23

Depressive disorders and immunity: 20 years of progress and discovery.
Michael R Irwin, Andrew H Miller. Brain Behav Immun 2007
432
23

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
23

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
M Maes, H Y Meltzer, E Bosmans, R Bergmans, E Vandoolaeghe, R Ranjan, R Desnyder. J Affect Disord 1995
449
20

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings.
D L Musselman, A H Miller, M R Porter, A Manatunga, F Gao, S Penna, B D Pearce, J Landry, S Glover, J S McDaniel,[...]. Am J Psychiatry 2001
308
19

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
19

Increase in interleukin-1beta in late-life depression.
Alan J Thomas, Sue Davis, Christopher Morris, Elizabeth Jackson, Richard Harrison, John T O'Brien. Am J Psychiatry 2005
217
17

Cytokines and major depression.
Olga J G Schiepers, Marieke C Wichers, Michael Maes. Prog Neuropsychopharmacol Biol Psychiatry 2005
796
17

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
519
17




Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
888
14

Indicators of immune activation in major depression.
A Sluzewska, J Rybakowski, E Bosmans, M Sobieska, R Berghmans, M Maes, K Wiktorowicz. Psychiatry Res 1996
299
14

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.
O Mikova, R Yakimova, E Bosmans, G Kenis, M Maes. Eur Neuropsychopharmacol 2001
215
14

Depression and immunity: a meta-analytic review.
T B Herbert, S Cohen. Psychol Bull 1993
537
14

Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
705
14

IL-6 levels decrease with SSRI treatment in patients with major depression.
Ayse Devrim Basterzi, Cigdem Aydemir, Cebrail Kisa, Sabahat Aksaray, Verda Tuzer, Kemal Yazici, Erol Göka. Hum Psychopharmacol 2005
159
14


Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
Triin Eller, Veiko Vasar, Jakov Shlik, Eduard Maron. Prog Neuropsychopharmacol Biol Psychiatry 2008
218
14

Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder.
María Eugenia Hernández, Danelia Mendieta, Daniel Martínez-Fong, Frida Loría, Julia Moreno, Iris Estrada, Rafael Bojalil, Lenin Pavón. Eur Neuropsychopharmacol 2008
104
14

Inflammatory markers in major depression and melancholia.
M Rothermundt, V Arolt, M Peters, H Gutbrodt, J Fenker, A Kersting, H Kirchner. J Affect Disord 2001
119
13

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
516
13

Clinical depression and inflammatory risk markers for coronary heart disease.
Gregory E Miller, Cinnamon A Stetler, Robert M Carney, Kenneth E Freedland, William A Banks. Am J Cardiol 2002
315
13

Cytokine production and serum proteins in depression.
A Seidel, V Arolt, M Hunstiger, L Rink, A Behnisch, H Kirchner. Scand J Immunol 1995
203
13

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
625
13


Clinical depression and regulation of the inflammatory response during acute stress.
Gregory E Miller, Nicolas Rohleder, Cinnamon Stetler, Clemens Kirschbaum. Psychosom Med 2005
179
13

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.
Thaddeus W W Pace, Tanja C Mletzko, Oyetunde Alagbe, Dominique L Musselman, Charles B Nemeroff, Andrew H Miller, Christine M Heim. Am J Psychiatry 2006
521
13

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
532
13

Th2 cytokine response in Major Depressive Disorder patients before treatment.
Lenin Pavón, Gabriel Sandoval-López, María Eugenia Hernández, Frida Loría, Iris Estrada, Mayra Pérez, Julia Moreno, Ulises Avila, Philippe Leff, Benito Antón,[...]. J Neuroimmunol 2006
98
13

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
13

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity.
Florian Kaestner, Michael Hettich, Marion Peters, Walter Sibrowski, Günter Hetzel, Gerald Ponath, Volker Arolt, Uwe Cassens, Matthias Rothermundt. J Affect Disord 2005
126
11

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.
A Kagaya, A Kugaya, M Takebayashi, M Fukue-Saeki, T Saeki, S Yamawaki, Y Uchitomi. Neuropsychobiology 2001
79
11


Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.
Cengiz Tuglu, S Hakan Kara, Okan Caliyurt, Erdal Vardar, Ercan Abay. Psychopharmacology (Berl) 2003
274
11

Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
Roberto Leo, Giorgio Di Lorenzo, Manfredi Tesauro, Cinzia Razzini, Giovanni B Forleo, Gaetano Chiricolo, Clarissa Cola, Marco Zanasi, Alfonso Troisi, Alberto Siracusano,[...]. J Clin Psychiatry 2006
71
11

Cytokine imbalance in the pathophysiology of major depressive disorder.
Yong-Ku Kim, Kyeong-Sae Na, Kyung-Ho Shin, Han-Yong Jung, So-Hyun Choi, Jung-Bum Kim. Prog Neuropsychopharmacol Biol Psychiatry 2007
213
11

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.
Sinead M O'Brien, Paul Scully, Peter Fitzgerald, Lucinda V Scott, Timothy G Dinan. J Psychiatr Res 2007
268
11


The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
Y-K Kim, I-B Suh, H Kim, C-S Han, C-S Lim, S-H Choi, J Licinio. Mol Psychiatry 2002
158
10

Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.
Salvatore Alesci, Pedro E Martinez, Sujata Kelkar, Ioannis Ilias, Donna S Ronsaville, Samuel J Listwak, Alejandro R Ayala, Julio Licinio, Herman K Gold, Mitchel A Kling,[...]. J Clin Endocrinol Metab 2005
255
10

Cytokine profiles in women with different subtypes of major depressive disorder.
A H Marques-Deak, F Lotufo Neto, W V Dominguez, A C Solis, D Kurcgant, F Sato, J M Ross, E B A Prado. J Psychiatr Res 2007
83
10

Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.
Marieke C Wichers, Gunter Kenis, Carsten Leue, Ger Koek, Geert Robaeys, Michael Maes. Biol Psychiatry 2006
57
12

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
Lucile Capuron, Charles L Raison, Dominique L Musselman, David H Lawson, Charles B Nemeroff, Andrew H Miller. Am J Psychiatry 2003
216
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.